Literature DB >> 20465378

Uncovering the PKR pathway's potential for treatment of tumors.

Zineb Mounir, Antonis E Koromilas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20465378     DOI： 10.2217/fon.10.45

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  6 in total

1.  Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.

Authors:  Kwanbok Lee; Nawapol Kunkeaw; Sung Ho Jeon; Inhan Lee; Betty H Johnson; Gum-Yong Kang; Joo Young Bang; Hyung Soon Park; Chanvit Leelayuwat; Yong Sun Lee
Journal:  RNA       Date:  2011-04-25       Impact factor: 4.942

Review 2.  Translational regulator eIF2α in tumor.

Authors:  Qiaoli Zheng; Jingjia Ye; Jiang Cao
Journal:  Tumour Biol       Date:  2014-03-09

Review 3.  The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.

Authors:  Sylvanne M Daniels; Anne Gatignol
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

4.  Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma.

Authors:  N Kunkeaw; S H Jeon; K Lee; B H Johnson; S Tanasanvimon; M Javle; C Pairojkul; Y Chamgramol; W Wongfieng; B Gong; C Leelayuwat; Y S Lee
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

5.  An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy.

Authors:  Cedric Darini; Nour Ghaddar; Catherine Chabot; Gloria Assaker; Siham Sabri; Shuo Wang; Jothilatha Krishnamoorthy; Marguerite Buchanan; Adriana Aguilar-Mahecha; Bassam Abdulkarim; Jean Deschenes; Jose Torres; Josie Ursini-Siegel; Mark Basik; Antonis E Koromilas
Journal:  Nat Commun       Date:  2019-05-13       Impact factor: 14.919

6.  Double-stranded RNA-dependent protein kinase regulates the motility of breast cancer cells.

Authors:  Mei Xu; Gang Chen; Siying Wang; Mingjun Liao; Jacqueline A Frank; Kimberly A Bower; Zhuo Zhang; Xianglin Shi; Jia Luo
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.